Newsfiscal.ai
InflaRx Presents New Pre-clinical Data on Izicopan at Kidney Week 2026
· Published
Article summary
InflaRx N.V. announced the presentation of new pre-clinical data for its lead candidate, izicopan, demonstrating its potential in treating complement-driven kidney diseases.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…